Summary. The effect of oral treatment of rats for 12 consecutive days with the contraceptive steroids, mestranol (0\m=.\08mg/rat/day) and lynoestrenol (2\m=.\5mg/rat/day), separately or in combination, on the sensitivity of the isolated spontaneously contracting rat uterus to the inhibitory action of isoprenaline, adrenaline and noradrenaline was investigated. The sensitivity to isoprenaline did not change significantly after any of the hormonal treatments. The sensitivity to adrenaline was significantly reduced after treatment with mestranol and lynoestrenol separately and together. Only mestranol treatment also resulted in a significant decrease in sensitivity to noradrenaline while the decrease after lynoestrenol or mestranol+ lynoestrenol was not significant. Treatment with only one or with a combination of the steroids resulted in the appearance of excitatory \g=a\-adrenoceptors which most probably contributed to the decrease in the sensitivity of the uterus to the inhibitory action of the sympathomimetic agents. The reactivity of the isolated rat uterus to the inhibitory action of some sym¬ pathomimetic agents depends on the types of adrenoceptors, the rate of binding, the enzymatic inactivation and the functional state of the uterus (see AbdelAziz & Bakry, 1973). After oestrogen treatment and during early pregnancy, there is a decrease in the sensitivity of the isolated rat uterus to some sympatho¬ mimetic agents (Abdel-Aziz & Bakry, 1973) .
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The present investigation deals with the effect of treatment with two contra¬ ceptive steroids, mestranol and lynoestrenol, on the sensitivity of the isolated rat uterus to the inhibitory action of some sympathomimetic agents.
Forty virgin female albino rats with a mean body weight ofl55 + 6-0g were allocated equally to four groups. The animals selected showed regular oestrous cycles. The contraceptive steroids were suspended in 0-5% (w/v) carboxymethylcellulose (CMC) and oral treatment with 0-2 ml CMC/day was con¬ tinued for 12 consecutive days. The first group received 0-08 mg mestranol/rat/ day, the second group received 2-5 mg lynoestrenol/rat/day and the third group received 0-08 mestranol+ 2-5 mg lynoestrenol/rat/day. The (Goldzieher, Moses & Ellis, 1962; Overbeek, Madjerek & de Visser, 1962; Gardner, Gnoj, Watnick & Gibson, 1964) .
The isolated spontaneously contracting rat uterus was prepared essentially as described by Tothill (1965) . The uterus was suspended in Locke solution at 37°C in a bath of 20-ml capacity and the bathing fluid was gassed with a mixture of 95% 02: 5% C02. Uteri suspended under such conditions showed fairly regular rhythmic contractions. The mean concentration of adrenaline, In the group treated with mestranol, in the absence of propranolol, adrenaline (0-8 to 2·7 ng/ml) and noradrenaline (115 to 170 ng/ml) resulted in inhibition of uterine contraction. In the presence of propranolol, the inhibitory action of adrenaline was blocked with no excitatory action but the action of noradrena¬ line was reversed to an excitatory one in nine out of fifteen uterine horns. In the group treated with lynoestrenol, the inhibitory action of adrenaline (0-6 to 1-3 ng/ml) was blocked when the agonist was added after propranolol, while the inhibitory effect of noradrenaline (40 to 60 ng/ml) was reversed to an excitatory action in three out of fifteen uterine horns when added after propran¬ olol. In three out of twelve uterine horns from rats treated with mestranol + lynoestrenol, the addition of noradrenaline (50 to 70 ng/ml), in the absence of propranolol, resulted in an excitatory action. In the presence of propranolol, the inhibitory action of adrenaline (0-6 to 2 ng/ml) was blocked but that of noradrenaline (50 to 70 ng/ml) was reversed to an excitatory action in seven out of twelve uterine horns. Phenoxybenzamine antagonized the excitatory effects of noradrenaline.
The changes in the sensitivity of the rat uterus to the inhibitory action of some sympathomimetic agents may to some extent depend on the appearance of excitatory a-adrenoceptors (Abdel-Aziz & Bakry, 1973) . In the present study, the sensitivity of the rat uterus to the inhibitory action of isoprenaline, a domin¬ ant /?-adrenoceptor agonist, did not show any significant change following treatment with the contraceptive steroids. This may indicate that such treat¬ ment did not affect the sensitivity or the population of the uterine inhibitory /?-adrenoceptors. The changes in the sensitivity ofthe rat uterus to the inhibitory action of adrenaline, known to act on both a-and yS-adrenoceptors and that of noradrenaline, a dominant a-adrenoceptor agonist, following treatment with oral contraceptive steroids, might partly be attributed to the appearance of excitatory a-adrenoceptors. The existence of such receptors would tend to antagonize the inhibitory action of sympathomimetic agents acting mainly through a-or a-plus /J-adrenoceptors. Excitatory a-adrenoceptors are reported to exist in conditions associated with elevated oestrogen levels (Tothill, 1967; Butterworth & Randall, 1970; Abdel-Aziz & Bakry, 1972) . The excitatory adrenoceptors observed in the present work are of the -type as they were blocked by phenoxybenzamine.
The vaginal smears of the rats treated with mestranol showed the expected induced oestrous state due to the oestrogenic activity of this steroid and many excitatory a-adrenoceptors were found in rats treated with this steroid. By contrast, lynoestrenol, in the dose used, was shown to possess a weak oestrogenic activity in addition to a dominant progestational action. The weak oestrogenic activity of lynoestrenol has also been reported by several workers (Overbeek et al., 1962; Okada, Amatsu, Ishihara & Tokuda, 1964; Paulsen, 1965) . It seems possible that the dominant progestational action of lynoestrenol is responsible for the failure of the appearance of excitatory a-adrenoceptors in the majority of rats treated with this steroid. This would also explain the finding that the decrease in the sensitivity of the rat uterus to the inhibitory action of adrenaline and noradrenaline was the least marked following treatment with lynoestrenol. The combined treatment with mestranol plus lynoestrenol resulted in the appearance of excitatory a-adrenoceptors in more than 50 % of the rats but the decrease in the sensitivity of the uterus to the sympathomimetic agents was less marked than that obtained with mestranol alone. From this, it can be concluded that the progestational effect of lynoestrenol tends to antagonize the effect of mestranol on the inhibitory action of some sympatho¬ mimetic agents on the uterus.
Factors other than the appearance of a-adrenoceptors may also contribute to the changes in the sensitivity of the rat uterus to the inhibitory action of sympathomimetic agents. Such factors include the changes in the degree of uptake or physiological binding, changes in the enzymatic inactivation of sympathomimetic agents as well as the changes produced by the contraceptive steroids on the properties of the myometrium.
